Figure 1From: Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation Overall survival stratified by neotrophil-lymphocyte ratio (NLR). Back to article page